CASI Pharmaceuticals, Inc.
CASIF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001962738
No open-market purchases or sales by CASI Pharmaceuticals, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $17 in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in CASI Pharmaceuticals, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +2 vs. Q3 2024
- Shares held
- 2.66M
- +1.34M (+101.0%) vs. Q3 2024
- Total value
- $7.52M
- −$615.9K (−7.6%) vs. Q3 2024
- New holders
- 4
- 2 more added
- Sold out
- 2
- 7 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CASIF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $17 |
| Q1 2026 | 1 | $25 |
| Q4 2025 | 16 | $1.06M |
| Q3 2025 | 22 | $4.33M |
| Q2 2025 | 24 | $2.66M |
| Q1 2025 | 23 | $5.93M |
| Q4 2024 | 22 | $7.52M |
| Q3 2024 | 20 | $8.14M |
| Q2 2024 | 23 | $1.94M |
| Q1 2024 | 20 | $920.0K |
| Q4 2023 | 18 | $1.99M |
| Q3 2023 | 19 | $882.6K |
| Q2 2023 | 19 | $1.12M |
| Q1 2023 | 21 | $2.15M |
| Q4 2022 | 1 | $179 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding CASI Pharmaceuticals, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Foresite Capital Management VI LLC | 1,329,383 | $3.76M | 1.68% | +1,329,383 | New |
| VR Adviser, LLC | 987,259 | $2.79M | 0.19% | 00.0% | Unchanged |
| Woodline Partners LP | 99,690 | $282.1K | 0.00% | +69,158+226.5% | Added |
| Wellington Shields Capital Management, LLC | 85,835 | $242.9K | 0.04% | −3,382−3.8% | Reduced |
| ADAR1 Capital Management, LLC | 46,320 | $131.1K | 0.03% | −18,515−28.6% | Reduced |
| Renaissance Technologies LLC | 39,400 | $111.5K | 0.00% | −2,100−5.1% | Reduced |
| Wellington Shields & Co., LLC | 30,091 | $85.2K | 0.03% | −13,000−30.2% | Reduced |
| Geode Capital Management, LLC | 19,363 | $54.8K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 11,308 | $32.0K | 0.00% | −3,373−23.0% | Reduced |
| Royal Bank of Canada | 6,900 | $20.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,490 | $4.22K | 0.00% | +50+3.5% | Added |
| Wells Fargo & Company | 505 | $1.43K | 0.00% | −1−0.2% | Reduced |
| BlackRock, Inc. | 296 | $838 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 134 | $379 | 0.00% | +134 | New |
| West Paces Advisors Inc. | 100 | $283 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 28 | $79 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 25 | $71 | 0.00% | −25−50.0% | Reduced |
| Northwestern Mutual Wealth Management Co | 13 | $37 | 0.00% | 00.0% | Unchanged |
| Colonial Trust Co | 11 | $31 | 0.00% | 00.0% | Unchanged |
| Trust Co of Vermont | 10 | $28 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 5 | $15 | 0.00% | +5 | New |
| Wingate Wealth Advisors, Inc. | 2 | $6 | 0.00% | +2 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −22,714−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −8−100.0% | Sold out |